February 2026
The global S1P receptor modulator drugs market size is estimated to hit around USD 6.96 billion by 2035 increasing from USD 3.16 billion in 2025, with a CAGR of 8.22%.
May 2026
The global hyperlipidemia drugs market size is calculated at USD 23.85 billion in 2025 and is projected to surpass USD 35.24 billion by 2035 with a CAGR of 3.98%.
May 2026
The global pain management drugs market size was valued at USD 87.19 billion in 2025 and is expected to hit around USD 130.8 billion by 2035, growing at a CAGR of 4.14%.
May 2026
The U.S. pain management drugs market size was estimated at USD 32.79 billion in 2025 and is projected to hit around USD 46.50 billion by 2035, at a CAGR of 3.56%.
May 2026
The global HIV drugs market size is estimated at USD 38.47 billion in 2025 and is projected to hit around USD 69.88 billion by 2035, growing at a CAGR of 6.15%.
May 2026
The global over the counter (OTC) drugs market size is expected to increase from USD 135.25 billion in 2025 and is expected to hit USD 256.87 billion by 2035, growing at a CAGR of 6.62%
May 2026
The global antifungal drugs market size was exhibited at USD 18.00 billion in 2025 and is projected to hit around USD 25.34 billion by 2035 with a CAGR of 3.49%.
May 2026
The global antiepileptic drugs market size was evaluated at USD 18.03 billion in 2025 and is predicted to hit around USD 30.80 billion by 2035, growing at a CAGR of 5.50%.
May 2026
The global sedative-hypnotic drugs market size was evaluated at USD 15.64 billion in 2025 and is predicted to hit around USD 31.94 billion by 2035, growing at a CAGR of 7.40%.
May 2026
The global synthetic lethality-based drugs and targets market size was evaluated at USD 1.86 billion in 2025 and is predicted to hit around USD 9.37 billion by 2035, growing at a CAGR of 17.52%.
May 2026
The global injectable peptides drugs market size was evaluated at USD 48.60 billion in 2025 and is predicted to hit around USD 117.18 billion by 2035, growing at a CAGR of 9.20%.
April 2026
The global antipsychotic drugs market size was valued at USD 19.61 billion in 2025 and is projected to cross around USD 34.86 billion by 2035 with a CAGR of 5.92%.
April 2026
The contraceptive drugs and devices market size reached USD 33.26 billion in 2025 and is projected to surpass around USD 58.87 billion by 2035, with a notable CAGR of 5.88%.
April 2026
The genitourinary drugs market size size is expected to increase to USD 33.51 billion by 2035 from USD 30.04 billion in 2025 with a CAGR 1.10%.
April 2026
The global multiple sclerosis drugs market size is estimated to hit around USD 49.13 billion by 2035, increasing from USD 22.96 billion in 2025, with a CAGR of 7.90%.
April 2026
The global amylin analog drugs market size was evaluated at USD 3.20 billion in 2025 and is predicted to hit around USD 7.10 billion by 2035, growing at a CAGR of 8.30%.
April 2026
The global ovarian cancer drugs market size was evaluated at USD 4.09 billion in 2025 and is predicted to hit around USD 7.78 billion by 2035, growing at a CAGR of 6.64%.
March 2026
The global veterinary dermatology drugs market size is expected to increase from USD 8.96 billion in 2025 and is projected to hit around USD 20.62 billion by 2035 with a CAGR of 8.69%.
March 2026
The global contraceptive drugs market size is valued at USD 19.00 billion in 2025 and is expected to hit around USD 33.23 billion by 2035, at a CAGR of 5.75%.
March 2026
The global intravenous iron drugs market size was valued at USD 3.84 billion in 2025 and is expected to attain around USD 8.82 billion by 2035 at a CAGR of 8.67%.
March 2026
The global kidney cancer drugs market size is calculated at USD 7.24 billion in 2025 and is projected to hit around USD 12.16 billion by 2035 with a CAGR of 5.32%.
March 2026
The global anti-obesity drugs market size is estimated at USD 7.14 billion in 2025, and is projected to hit around USD 64.96 billion by 2035, with a CAGR of 24.71%.
March 2026
The global asthma and COPD drugs market size is expected to increase from USD 43.49 billion in 2025 to hit around USD 92.39 billion by 2035, with a CAGR of 7.83%.
March 2026
The global allergy rhinitis drugs market size is expected to increase from USD 14.58 billion in 2025 to hit around USD 21.61 billion by 2035, growing at a CAGR of 4.01%.
March 2026
The global smart drugs market size was evaluated at USD 2.30 billion in 2025 and is predicted to hit around USD 6.24 billion by 2035, growing at a CAGR of 10.50%.
March 2026
The global UTI drugs market size was evaluated at USD 5.06 billion in 2025 and is predicted to hit around USD 8.65 billion by 2035, growing at a CAGR of 5.50%.
March 2026
The global muscle relaxant drugs market size is estimated to hit around USD 7.64 billion by 2035 increasing from USD 4.80 billion in 2025, with a CAGR of 4.76%.
February 2026
The global anti-epileptic drugs for pediatrics market size is estimated to hit around USD 3.25 billion by 2035 increasing from USD 1.50 billion in 2025, with a CAGR of 8.04%.
February 2026
The global GnRH receptor antagonists market size was evaluated at USD 2.32 billion in 2025 and is predicted to hit around USD 5.25 billion by 2035, growing at a CAGR of 8.50%.
February 2026
The global companion animal drugs market size was evaluated at USD 15.77 billion in 2025 and is projected to reach around USD 29.42 billion by 2035, at a CAGR of 6.43%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com